QHSLab, Inc. (USAQ): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$90.7K
Year ended 2025-12-31
$72.1K
Trailing 12 months to 2026-06-30
-10.8%
3-year compound annual growth
$146.6K2021-12-31: $36.1K2022-12-31: $128.0K2023-12-31: $146.6K2024-12-31: $146.6K2025-12-31: $90.7K$90.7K
2021-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$90.7K-38.1%2026-03-30, From 2025-01-01
2024-12-31$146.6K0.0%2026-03-30, From 2024-01-01
2023-12-31$146.6K+14.5%2025-03-28, From 2023-01-01
2022-12-31$128.0K+254.9%2024-03-27, From 2022-01-01
2021-12-31$36.1Kn/a2023-03-29, From 2021-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
QHSLab, Inc. (USAQ)2025-12-31$90.7K-38.1%
Femasys Inc (FEMY)2025-12-31$342.0K+15.0%
Vycor Medical Inc (VYCO)2025-12-31$59.5K0.0%
Tenon Medical, Inc. (TNON)2025-12-31$262.0K-35.8%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$1.16M-3.6%
EBR Systems, Inc. (NONE.)2025-12-31$403.0K-31.3%
Lucid Diagnostics Inc. (LUCD)2025-12-31$872.0K-25.3%
Picard Medical, Inc. (PMI)2025-12-31$163.0K-27.9%
Cerenome, Inc. (CNSY)2025-12-31$445.0K-49.0%

Compare USAQ, FEMY, VYCO, TNON side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗